Concepedia

Henry H. Holzgrefe

HH

Statistics

Publications

24

Citations

1.2K

H-Index

17

Active since

1981

Affiliations

Bristol-Myers Squibb (United States)(Current)

Medical University of South Carolina

Charles River Laboratories (United States)

Roche (Switzerland)

A.S. Watson (Netherlands)

Henry H. Holzgrefe is an author at Bristol-Myers Squibb (United States) specializing in cardiology, medicine, and pharmacology.

ORCID

Publications per year

1981–2017

24

Publications

24

Myocardial thallium-201 kinetics in normal and ischemic myocardium.

Andrew M. Grunwald, Denny D. Watson, Henry H. Holzgrefe et al. · Circulation · 1981 · 144 citations · Full text

, , +14

Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation

Kathryn Chapman, Henry H. Holzgrefe, Lauren E. Black et al. · Regulatory Toxicology and Pharmacology · 2013 · 135 citations · Full text

, , +17

Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201.

G A Beller, Henry H. Holzgrefe, Denny D. Watson · Circulation · 1983 · 106 citations · Full text

, , +17

Angiotensin-Converting Enzyme Inhibition and the Progression of Congestive Cardiomyopathy

Francis G. Spinale, Henry H. Holzgrefe, Rupak Mukherjee et al. · Circulation · 1995 · 105 citations

, , +13

Preclinical QT safety assessment: Cross-species comparisons and human translation from an industry consortium

Henry H. Holzgrefe, Georg Ferber, Pascal Champéroux et al. · Journal of Pharmacological and Toxicological Methods · 2013 · 83 citations · Full text

, , +17

1–5 of 24